These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33508890)

  • 1. Exosomal NNMT from peritoneum lavage fluid promotes peritoneal metastasis in gastric cancer.
    Zhu AK; Shan YQ; Zhang J; Liu XC; Ying RC; Kong WC
    Kaohsiung J Med Sci; 2021 Apr; 37(4):305-313. PubMed ID: 33508890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition.
    Li Q; Li B; Li Q; Wei S; He Z; Huang X; Wang L; Xia Y; Xu Z; Li Z; Wang W; Yang L; Zhang D; Xu Z
    Cell Death Dis; 2018 Aug; 9(9):854. PubMed ID: 30154401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal miR-106a derived from gastric cancer promotes peritoneal metastasis via direct regulation of Smad7.
    Zhu M; Zhang N; He S; Lu X
    Cell Cycle; 2020 May; 19(10):1200-1221. PubMed ID: 32267797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer.
    Hu Y; Qi C; Liu X; Zhang C; Gao J; Wu Y; Yang J; Zhao Q; Li J; Wang X; Shen L
    Cancer Lett; 2019 Aug; 457():142-150. PubMed ID: 31075288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
    Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
    PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular vesicle derived miR-544 downregulates expression of tumor suppressor promyelocytic leukemia zinc finger resulting in increased peritoneal metastasis in gastric cancer.
    Kong W; Liu X; Yin G; Zheng S; Zhu A; Yu P; Shan Y; Ying R; Zhang J
    Aging (Albany NY); 2020 Nov; 12(23):24009-24022. PubMed ID: 33221764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-mesothelium HOXA11-PDGF BB/TGF β1-miR-181a-5p-Egr1 feedforward amplifier circuity propels mesothelial fibrosis and peritoneal metastasis of gastric cancer.
    Wang C; Ji J; Jin Y; Sun Y; Cai Q; Jiang J; Guo L; Zhou C; Zhang J
    Oncogene; 2024 Jan; 43(3):171-188. PubMed ID: 37989866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of gastric cancer cell adhesion through transforming growth factor-beta1-mediated peritoneal fibrosis.
    Lv ZD; Na D; Liu FN; Du ZM; Sun Z; Li Z; Ma XY; Wang ZN; Xu HM
    J Exp Clin Cancer Res; 2010 Oct; 29(1):139. PubMed ID: 21034459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of exosomal miR‑29s in peritoneal fluid is a useful predictor of peritoneal recurrence after curative resection of gastric cancer with serosal involvement.
    Ohzawa H; Saito A; Kumagai Y; Kimura Y; Yamaguchi H; Hosoya Y; Lefor AK; Sata N; Kitayama J
    Oncol Rep; 2020 Apr; 43(4):1081-1088. PubMed ID: 32323853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β1 induces peritoneal fibrosis by activating the Smad2 pathway in mesothelial cells and promotes peritoneal carcinomatosis.
    Lv ZD; Wang HB; Li FN; Wu L; Liu C; Nie G; Kong B; Qu HL; Li JG
    Int J Mol Med; 2012 Mar; 29(3):373-9. PubMed ID: 22139024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal hsa-let-7g-3p and hsa-miR-10395-3p derived from peritoneal lavage predict peritoneal metastasis and the efficacy of neoadjuvant intraperitoneal and systemic chemotherapy in patients with gastric cancer.
    Luo J; Jiang L; He C; Shi M; Yang ZY; Shi M; Lu S; Li C; Zhang J; Yan M; Zhu ZG; Yan C
    Gastric Cancer; 2023 May; 26(3):364-378. PubMed ID: 36738390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytotoxic effect of TGF-β1 on mesothelial cells via apoptosis in early peritoneal carcinomatosis.
    Lv ZD; Yang ZC; Wang HB; Li JG; Kong B; Wang XG; Liu XY; Niu ZH; Wang Y; Nie G
    Oncol Rep; 2012 Jun; 27(6):1753-8. PubMed ID: 22447164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal miR-493 suppresses MAD2L1 and induces chemoresistance to intraperitoneal paclitaxel therapy in gastric cancer patients with peritoneal metastasis.
    Makinoya M; Miyatani K; Matsumi Y; Sakano Y; Shimizu S; Shishido Y; Hanaki T; Kihara K; Matsunaga T; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Saito H; Nakayama Y; Osaki M; Okada F; Fujiwara Y
    Sci Rep; 2024 May; 14(1):10075. PubMed ID: 38698201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-431-5p inhibits angiogenesis, lymphangiogenesis, and lymph node metastasis by affecting TGF-β1/SMAD2/3 signaling via ZEB1 in gastric cancer.
    Liu P; Ding P; Yang J; Wu H; Wu J; Guo H; Yang P; Tian Y; Meng L; Zhao Q
    Mol Carcinog; 2024 Jul; 63(7):1378-1391. PubMed ID: 38656643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis.
    Okugawa Y; Toiyama Y; Hur K; Toden S; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Kusunoki M; Boland CR; Goel A
    Carcinogenesis; 2014 Dec; 35(12):2731-9. PubMed ID: 25280565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta1 produced in autocrine/paracrine manner affects the morphology and function of mesothelial cells and promotes peritoneal carcinomatosis.
    Na D; Lv ZD; Liu FN; Xu Y; Jiang CG; Sun Z; Miao ZF; Li F; Xu HM
    Int J Mol Med; 2010 Sep; 26(3):325-32. PubMed ID: 20664947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking EGR1/TGF-β1 and CD44s/STAT3 Crosstalk Inhibits Peritoneal Metastasis of Gastric Cancer.
    Jin Y; Wang C; Zhang B; Sun Y; Ji J; Cai Q; Jiang J; Zhang Z; Zhao L; Yu B; Zhang J
    Int J Biol Sci; 2024; 20(4):1314-1331. PubMed ID: 38385088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASPP2 suppresses invasion and TGF-β1-induced epithelial-mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer.
    Gen Y; Yasui K; Kitaichi T; Iwai N; Terasaki K; Dohi O; Hashimoto H; Fukui H; Inada Y; Fukui A; Jo M; Moriguchi M; Nishikawa T; Umemura A; Yamaguchi K; Konishi H; Naito Y; Itoh Y
    Cancer Lett; 2017 Jul; 398():52-61. PubMed ID: 28400336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TTPAL promotes gastric tumorigenesis by directly targeting NNMT to activate PI3K/AKT signaling.
    Liu W; Gou H; Wang X; Li X; Hu X; Su H; Li S; Yu J
    Oncogene; 2021 Dec; 40(49):6666-6679. PubMed ID: 34642500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDCD4 regulates apoptosis in human peritoneal mesothelial cells and promotes gastric cancer peritoneal metastasis.
    Wu P; Wang J; Mao X; Xu H; Zhu Z
    Histol Histopathol; 2021 Apr; 36(4):447-457. PubMed ID: 33442866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.